$EVFM Cashflow Statement | Understand Stock

$EVFM

$0.01 +$0.00 (2.67%) Close

$EVFM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net restricted cash and cash equivalents used in operating activities:
Change in fair value of financial instruments
Loss on issuance of financial instruments
Gain on debt extinguishment

Gain on change in accounting estimates on contingent royalty liability
Change in fair value of financial instruments
Financial instrument modification expense
Inventory write-down for excess & obsolescence
Inventory write-down for excess & obsolescence and loss on purchase commitment
Loss on contingent liability
Stock-based compensation
Noncash lease expenses
Depreciation
Amortization of intangible asset
Noncash interest expense
Noncash right-of-use amortization
Noncash right-of-use asset amortization
Net gain on lease termination
Noncash instrument exchange expense
Net loss on disposal or impairment of property and equipment
Gain on accounts payable and accrued expenses settlements
Changes in operating assets and liabilities:
Trade accounts receivable
Inventories
Prepaid and other assets
Accounts payable
Accrued expenses and other liabilities
Accrued compensation
Lease liabilities
Contingent liabilities
Operating lease liabilities
Net restricted cash and cash equivalents used in operating activities

Proceeds from sale of Softcup line of business
Cash flows from investing activities:
Payments related to asset acquisition
Payments related to intangible asset acquisition
Purchases of property and equipment
Maturities of short-term investments
Net restricted cash and cash equivalents used in investing activities

Cash flows from financing activities:
Proceeds from issuance of common stock and warrants, net of discounts and commissions - public offerings
Proceeds from issuance of common stock - exercise of warrants
Proceeds from issuance of common stock, net of commissions - ATM transactions
Proceeds from issuance of common stock - ESPP and exercise of stock options
Proceeds from issuance of common stock and warrants, net of offering costs
Proceeds from issuance of common stock – Public Offering, net of commissions – ATM transactions
Proceeds from issuance of common stock- ESPP and exercise of stock options
Borrowings under term notes
Short-swing profit disgorgement
Payments under term notes
Cash repurchase of fractional common stock after reverse stock split
Payments of tax withholdings related to vesting of restricted stock awards
Cash paid for offering costs
Borrowings under short-term debt
Proceeds from issuance of Aditxt Notes – Related Party
Proceeds from issuance of Series F-1 Shares to Aditxt, including reinstatement proceeds - Related Party
Payments under short-term debt and Notes – carried at fair value
Cash paid for financing costs
Net restricted cash and cash equivalents provided by financing activities

Net change in restricted cash and cash equivalents
Restricted cash and cash equivalents, beginning of period
Restricted cash and cash equivalents, end of period
Supplemental cash flow information:
Cash paid for interest
Cash paid for taxes
Supplemental disclosure of noncash investing and financing activities:
Exchange of convertible notes to Series E-1 Shares
Exchange of warrants and partial purchase rights value to Series F-1 Shares
Series E-1 Shares deemed dividends
Right-of-use assets obtained in exchange for operating lease liabilities
Reclassification of financial instruments liability to equity
Conversion of series B-2 and B-1 convertible preferred stock to common stock
Exchange of series B-2 convertible preferred stock to series C convertible preferred stock
Right-of-use assets obtained for lease liabilities (fleet lease renewals)
Net increase/(decrease) in contingent liabilities
Exchange of convertible notes to Series G-1 convertible and redeemable preferred stock
Series E-1 and G-1 Shares deemed dividends
Addition to ROU asset and lease liability due to new leases
Purchases of property and equipment included in accounts payable and accrued expenses
Incurrence of contingent liabilities
Issuance of Common Stock upon exercise of purchase rights
Issuance of common stock from exercise of Purchase Rights
Exchange of Adjuvant Notes for Purchase Rights
Exchange of term notes for Purchase Rights
Issuance of Common Stock upon conversion of notes
Issuance of Common Stock upon exercise of warrants

Comments